Dr. Reddy's Laboratories
228 hedge funds and large institutions have $1.5B invested in Dr. Reddy's Laboratories in 2025 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 86 increasing their positions, 75 reducing their positions, and 39 closing their positions.
15% more repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 75
0.06% less ownership
Funds ownership: 12.88% → 12.82% (-0.06%)
6% less funds holding
Funds holding: 243 → 228 (-15)
7% less capital invested
Capital invested by funds: $1.62B → $1.5B (-$120M)
33% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 39
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
91% less call options, than puts
Call options by funds: $3K | Put options by funds: $35K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$21.1M |
| 2 |
Robeco Institutional Asset Management
Rotterdam,
Netherlands
|
+$13.3M |
| 3 |
BlackRock
New York
|
+$10.4M |
| 4 |
AIM
Aikya Investment Management
London,
United Kingdom
|
+$5.18M |
| 5 |
Caisse de Depot et Placement du Quebec (CDPQ)
Montreal,
Quebec, Canada
|
+$5.11M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$18.9M |
| 2 |
Millennium Management
New York
|
-$14M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$8.34M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$6.65M |
| 5 |
William Blair Investment Management
Chicago,
Illinois
|
-$5.49M |
RDY Hedge Fund Activity: Q3 2025 in Review
228 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q3 2025, worth a combined $1.5B — down 7.4% from $1.62B a quarter earlier.
Sellers outnumbered buyers: 39 funds closed out of RDY and 26 opened new positions — a net loss of 13 holders — while 75 trimmed existing stakes and 86 added.
The largest buyer was Morgan Stanley, adding an estimated $21.1M. The largest seller was Geode Capital Management, cutting an estimated $18.9M.
- 228 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q3 2025, down from 243 in Q2 2025.
- Funds reported $1.5B of Dr. Reddy's Laboratories stock for Q3 2025, down 7.4% quarter-over-quarter.
- 26 funds opened new Dr. Reddy's Laboratories positions in Q3 2025 and 39 closed out, a net change of -13 holders.
- The largest Dr. Reddy's Laboratories buyer in Q3 2025 was Morgan Stanley, an estimated $21.1M added.
- The largest Dr. Reddy's Laboratories seller in Q3 2025 was Geode Capital Management, an estimated $18.9M sold.
Based on aggregated 13F filings for Q3 2025.